Ligand Pharma: Expect Bright And Exciting Future For This Growing Royalty Aggregator

Ligand Pharmaceuticals has delivered exceptional long-term returns, rising from ~$86 to nearly $300 over six years. Read why LGND stock is a Buy.
The Motley Fool

Defense Stock Showdown: SpaceX vs. Lockheed Martin -- Which Is the Smarter Long-Term Buy?

Space offers several growth opportunities for defense companies, including satellite constellations for communications and surveillance, orbital data centers, and the Golden Dome, a planned ...
Investopedia

Level Up Your Investing Strategy: 7 Smart Ways To Transform Your Approach

Meagan is a former Series 7 financial advisor and current writer focused on blending straightforward information with a dose of humor on topics including equity investments, insurance products, and ...
MSN on MSN

Martin Shkreli accuses IONQ of making wild Bitcoin mining claims: 'They were lying'

Martin Shkreli, also known as “Pharma Bro,” has escalated his stand against quantum computing firm IONQ Inc. (NYSE:IONQ), accusing the company of peddling exaggerated capabilities to crypto investors.